Latest news with #Dr.AgarwalsEyeHospital
The Hindu
10 hours ago
- Health
- The Hindu
Dr. Agarwals Eye Hospital partners with Japanese firm to research myopia control treatment
Dr. Agarwals Eye Hospital has partnered with Menicon Co. Ltd, a Japan-based contact lens manufacturing company, to undertake research and development in myopia control treatment. They have started clinical studies in India using an orthokeratology lens that is worn overnight to improve vision, with the aim of checking its efficacy and safety for children in India. On Monday, Ashvin Agarwal, chief clinical officer, Dr. Agarwals Eye Hospital, and Shunsuke Yamagishi, regional director, China and Asia-Oceania International Business Head Office, Menicon Co. Ltd, signed a Memorandum of Understanding for joint research and development efforts to develop myopia control treatment, training ophthalmologists and optometrists, raising awareness on the treatment as well as expansion plans in India and neighbouring regions, according to a press release. Myopia cases have increased significantly in India from 4% in 1999 to 21% in 2019. It is expected to grow to 30% in the next five years, to 40% by 2040 and 48% by 2050, Dr. Ashvin said. One of the main aims of this tie-up is to reduce the incidence of myopia, he added. Backed by the Japanese government, they have initiated the study to explore effective strategies for controlling and mitigating vision-related issues. The study was launched by the Research and Development unit of the clinical board of the hospital. Orthokeratology lenses are custom-made and designed to gently reshape the cornea to correct myopia, the release said. The technology was to basically help patients at risk of myopia, such as those with a family history and those with the early stages of the condition, Dr. Ashvin said. With the growing challenges of myopia, this partnership marks a significant step towards tackling the issue, Mr. Yamagishi said. S.V. Chandrakumar, project director, State Programme Officer, Tamil Nadu State Blindness Control Society, took part.
The Hindu
04-05-2025
- Health
- The Hindu
Conference to discuss advancements in retina care held in city
'RETICON 2025', a conference to discuss various advancements in retina care organised by Dr. Agarwals Eye Hospital, was held in the city on Sunday. Ashvin Agarwal, chief clinical officer, Dr. Agarwals Eye Hospital, said that, back in 2011, the conference was started as an initiative with an idea to spotlight advanced technology and foster discussions on retina care. 'Today in 'RETICON 2025', there is everything – from panel discussions to talks – to provide insights. It becomes important to highlight the issues [in the retina] and the advancements in treatment to not just current surgeons but also to budding retinal surgeons and young ophthalmologists. The conference is a cross pollination of ideas and discussions,' he said. Amar Agarwal, chairman, Dr. Agarwals Eye Hospital, says today in India, there are nearly two crore people with blindness and one of the biggest diseases in India is diabetes. 'Getting your eyes checked every six months should be a prerogative when you are diagnosed with diabetes. Because, even if diabetes is well-controlled in someone, he/she can get bleeding in the eye. But if we immediately get it treated, it can be solved easily,' he said. The conference focused on techniques, such as glued intraocular lens, scleral fixated techniques, and intravitreal injections, and also featured a wet-lab to provide practical training. Mohan Rajan, vice-president of All India Ophthalmological Society and chairman and medical director of Rajan Eye Care hospital, said: 'Such focus meetings are extremely important, useful, and informative.' Chennai North MP Kalanidhi Veeraswamy and Athiya Agarwal, director, Dr. Agarwals Group of Eye Hospitals, also spoke.
